European shares edge higher as traders brace for data-packed week
For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window
STOXX 600 up 0.2%
Euro zone PMI at 48.9 in September
Commerzbank falls as German government retains 12% stake
Updated at 0823 GMT
By Pranav Kashyap
Sept 23 (Reuters) -European shares edged higher on Monday, though gains were capped by caution as investors tread carefully in anticipation of a wave of crucial economic data from the region this week.
The pan-European STOXX 600 index .STOXX was up 0.2% at 515.5 points. The benchmark posted its worst day in more than a month on Friday.
Business activity in the euro zone contracted unexpectedly in September, according to data released earlier in the day. The bloc's PMI sank to 48.9 from 51 in August.
The downturn appeared broadbased with Germany, Europe's largest economy, seeing its decline deepen while France - the currency union's second biggest - returned to contraction following August's Olympics boost.
Germany's DAX .GDAXI edged 0.3% higher after PMI figures showed that business activity contracted in September at its sharpest pace in seven months.
France's CAC 40 .FCHI lost 0.3% after data signalled its services sector contracted sharply in September.
British flash PMI figures for September are expected at 0830 GMT.
Board members from the European Central Bank are set to speak through the week, with Frank Elderson and Piero Cipollone speaking later in the day.
The euphoria from the U.S. Federal Reserve's jumbo rate cut, which had sparked a market rally globally, is fading as investors shift their focus to potential further cuts.
Attention is on the core personal consumption expenditures (PCE) index, the Fed's preferred inflation measure, due on Friday. This data will indicate if more rate adjustments are imminent.
"The number of cuts is not the main risk to equities. It is a much weaker growth," Lilian Chovin, head of asset allocation at Coutts said.
"What's next for European equities - you want to start seeing an uplift in earnings, which haven't been very strong."
The Swiss National Bank is expected to cut rates by a quarter point on Thursday, while Sweden's central bank is anticipated to ease by 25 basis points on Wednesday.
Among individual stock moves, HSBC Holdings HSBA.L rose 1.1% after BNP Paribas BNPP.PA signed a deal to buy the lender's private banking unit in Germany.
Shares of Germany's Commerzbank CBKG.DE fell 4.4% as the government said it would retain its 12% stake in the lender, that will likely keep any merger with Italy's UniCredit CRDI.MI on hold.
The banking sector .SX7E lost 1.1%.
AstraZeneca AZN.L dropped 1% after its experimental precision drug developed with Daiichi Sankyo 4568.T did not significantly improve overall survival for patients with a type of breast cancer in a late-stage trial.
China's central bank lowering its 14-day repo rate by 10 basis points is also acting as a slight tailwind for Europe stocks.
"There are rumours that there's going to be more stimulus in the coming days. That is what could really help support activity in China and manufacturing activity and the stock markets in Europe," Coutts' Chovin said.
Reporting by Pranav Kashyap in Bengaluru; Editing by Sherry Jacob-Phillips
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
